Moleculin BiotechMBRX 
$2.19-5.60%24h
-5.60%24h
Global rank4031
Market cap$73.17M
Change 7d-20.36%
YTD Performance155.24%
SP500 benchmarkOutperform
P/E0
P/S0
Revenue$0
Earnings$0
Dividend yield-
Market capitalization of Moleculin Biotech (MBRX)
As of December 2024, Moleculin Biotech has a market cap of $73.17M. This makes Moleculin Biotech the world's 4031th valuable company by market cap, according to our data. The market capitalization, also known as a stock market cap is a key financial indication. It represents the combined worth of all the outstanding shares of a publicly traded company multiplied by the current stock price. This figure is often used to see how much a company is worth. This figure is often used to see what is the company net worth.
Market cap history of Moleculin Biotech from 2016 to 2024
-
Value:-
Market cap history of Moleculin Biotech from 2016 to 2024
| Year | Market Cap | Change |
|---|---|---|
| 2024 | $17.21M | -39.98% |
| 2023 | $28.67M | -19.06% |
| 2022 | $35.42M | -43.01% |
| 2021 | $62.15M | -61.10% |
| 2020 | $159.78M | -12.90% |
| 2019 | $183.44M | -12.02% |
| 2018 | $208.50M | -44.09% |
| 2017 | $372.89M | -18.42% |
| 2016 | $457.09M | - |
MBRX Market Cap Today is $73.17M -5.60% - 18 Dec 2024
View largest stocks by market cap 
